NasdaqCM - Nasdaq Real Time Price USD
Regencell Bioscience Holdings Limited (RGC)
31.41 +0.64 (+2.08%)
At close: 4:00:01 PM EST
30.99 -0.42 (-1.34%)
After hours: 4:02:21 PM EST
Chart Range Bar
Loading chart for RGC
- Previous Close
30.77 - Open
31.00 - Bid 26.93 x 200
- Ask 38.01 x 200
- Day's Range
28.00 - 37.80 - 52 Week Range
0.09 - 83.60 - Volume
1,155,770 - Avg. Volume
436,944 - Market Cap (intraday)
15.532B - Beta (5Y Monthly) 2.02
- PE Ratio (TTM)
-- - EPS (TTM)
-0.01 - Earnings Date (est.) Nov 18, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
www.regencellbioscience.com10
Full Time Employees
June 30
Fiscal Year Ends
Sector
Recent News: RGC
View More
Performance Overview: RGC
Trailing total returns as of 1/23/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
RGC
49.57%
S&P 500 (^GSPC)
1.02%
1-Year Return
RGC
24,922.71%
S&P 500 (^GSPC)
13.02%
3-Year Return
RGC
4,066.08%
S&P 500 (^GSPC)
72.04%
5-Year Return
RGC
9,846.52%
S&P 500 (^GSPC)
80.03%
Statistics: RGC
View MoreValuation Measures
As of 1/22/2026
Market Cap
15.21B
Enterprise Value
15.21B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
3.13k
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-33.20%
Return on Equity (ttm)
-54.81%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-3.58M
Diluted EPS (ttm)
-0.01
Balance Sheet and Cash Flow
Total Cash (mrq)
4.9M
Total Debt/Equity (mrq)
11.20%
Levered Free Cash Flow (ttm)
-1.51M
Compare To: RGC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
31.41
+2.08%
Mkt Cap 15.532B
Industry Drug Manufacturers—Specialty & Generic
2.5000
+5.93%
Mkt Cap 4.809M
Industry Drug Manufacturers—Specialty & Generic
0.7900
-14.49%
Mkt Cap 3.093M
Industry Drug Manufacturers—Specialty & Generic
29.62
-2.96%
Mkt Cap 6.742B
Industry Drug Manufacturers—Specialty & Generic
5.23
-2.97%
Mkt Cap 850.809M
Industry Drug Manufacturers—Specialty & Generic
0.3441
-3.99%
Mkt Cap 119.136M
Industry Drug Manufacturers—Specialty & Generic
1.1900
+1.71%
Mkt Cap 480.908M
Industry Drug Manufacturers—Specialty & Generic
0.0856
-5.62%
Mkt Cap 10.959M
Industry Drug Manufacturers—Specialty & Generic
3.2400
-0.31%
Mkt Cap 395.29M
Industry Drug Manufacturers—Specialty & Generic
Company Insights: RGC
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected. Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.